基于(关键地区、市场参与者、规模和份额)的特种活性药物成分 (API) 市场 - 到 2031 年的预测

  • Report Code : TIPRE00005913
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

特种活性药物成分 (API) 市场预计在 2023 年至 2031 年期间的复合年增长率为 6.7%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

本报告重点关注特种活性药物成分 (API) 市场,探索其按产品类型、应用和地区细分的情况。报告探讨了生物制剂和个性化医疗等主要趋势,推动了对专用 API 的需求。市场规模、增长预测和竞争格局分析为利益相关者提供了有关这一利基医药市场当前动态和未来机遇的重要见解。

报告目的

The Insight Partners 发布的《特种活性药物成分 (API) 市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

特种活性药物成分 (API) 市场细分

 

消耗

  • 小分子
  • 寡核苷酸
  • 碳水化合物药物
  • 类固醇药物
  • 管制物质
  • 高效原料药

产品类型

  • 糖类
  • 甾体类原料药
  • 管制物质 API

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

特种活性药物成分 (API) 市场:战略洞察

Specialty Active Pharmaceutical Ingredients (API) Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

特种活性药物成分 (API) 市场增长动力

  • 慢性病发病率不断上升:对复杂药物和靶向疗法的需求不断增长,加上肿瘤学和慢性病发病率不断上升,是特种活性药物成分 (API) 市场的主要市场驱动力。
  • 需要开发特殊 API:需要开发具有持续质量的特殊 API,以及制造工艺(例如连续加工和自动化系统)的技术进步,为有效、高效生产所需药物提供平台。
  • 监管压力下的高质量产品:例如美国的 FDA 和欧洲的 EMA 开始收紧标准,从而迫使公司依赖只有在严格质量控制下才能生产的高级专有 API。
  • 转向个性化医疗:个性化医疗是趋势之一,根据个人基因特征定制治疗方案。这需要针对特定​​基因标记或疾病特征而设计的专用 API。

特种活性药物成分 (API) 市场未来趋势

  • 生物技术和生物加工技术的进步:生物技术和生物加工技术的进步使新型高品质特种 API 的开发成为可能。重组 DNA 技术、发酵工艺和细胞培养系统的创新提高了生物制药 API 的生产能力,从而带来了更高效、更可扩展的生产方法。
  • 转向合成生物学:特种 API 生产的另一个主要趋势是合成生物学。通过这种方法,可以使用能够高效生产复杂分子的合成生物体设计来创建新型定制 API。随着这项技术的成熟,它有望彻底改变 API 制造工艺。
  • 加大对专科药物的研发投入:制药公司正在大力投资研发,以发现新的专科药物和靶向疗法。这项研究推动了对生产这些复杂药物所必需的专科 API 的需求,尤其是在肿瘤学、免疫学和罕见疾病领域。

特种活性药物成分 (API) 市场机会

  • 增加生物制剂的使用:从模具到填充 API 制造商的出现和外包 API 服务的增加,导致全球医疗保健市场中生物制剂和特种 API 的利用率不断提高。
  • 对 API 化学的投资:对针对小众治疗领域和孤儿病的新型 API 化学的投资、由于生物制药研发和慢性病增加而对新型生物分子的投资、由于疗效和可负担性而对仿制药和生物类似药的吸收。
  • 战略伙伴关系和协作:制药公司和合同制造商或 CDMO 之间的协作可以增强专业 API 的开发和生产。

 

特种活性药物成分 (API) 市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响特种活性药物成分 (API) 市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的特种活性药物成分 (API) 市场细分和地理位置。

Specialty Active Pharmaceutical Ingredients (API) Market
  • 获取特种活性药物成分 (API) 市场的区域特定数据

特种活性药物成分 (API) 市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)6.7%
史料2021-2022
预测期2024-2031
涵盖的领域按消费量
  • 小分子
  • 寡核苷酸
  • 碳水化合物药物
  • 类固醇药物
  • 管制物质
  • 高效原料药
按产品类型
  • 糖类
  • 甾体类原料药
  • 管制物质 API
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 阿尔马克
  • 昂博生物科技有限公司
  • 桑塔里斯制药公司
  • Symbiotec Pharma Lab Pvt. Ltd
  • 欧隆公司
  • 罗德斯科技
  • 普凡斯蒂尔公司
  • 德克斯特实验室有限公司
  • FarmaBios 水疗中心

 

特种活性药物成分 (API) 市场参与者密度:了解其对业务动态的影响

特种活性药物成分 (API) 市场正在快速增长,这得益于最终用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在特种活性药物成分 (API) 市场运营的主要公司有:

  1. 阿尔马克
  2. 昂博生物科技有限公司
  3. 桑塔里斯制药公司
  4. Symbiotec Pharma Lab Pvt. Ltd
  5. 欧隆公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Specialty Active Pharmaceutical Ingredients (API) Market

 

  • 获取特种活性药物成分 (API) 市场顶级关键参与者概览

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了特种活性药物成分 (API) 市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,关于特种活性药物成分 (API) 市场的研究报告可以帮助引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the deliverable formats of the Specialty Active Pharmaceutical Ingredients (API) Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are key players in Specialty Active Pharmaceutical Ingredients (API) Market?

Leading companies in this market are - Almac, AmbioPharm Inc, Santaris Pharma, Symbiotec Pharma Lab Pvt Ltd, Olon SpA, Rhodes Technologies, Pfanstiehl Inc, Dextra Laboratories Limited, FarmaBios Spa

What is expected CAGR in the Specialty Active Pharmaceutical Ingredients (API) Market?

The market is expected to register a CAGR of 6.7% during 2023-2031

What are factors impacting on the Specialty Active Pharmaceutical Ingredients (API) market?

The marijuana industry is poised for fast-paced growth due to the rising demand for targeted therapies for chronic patient health and newer tailored medicines. The demand in the Specialty Active Pharmaceutical Ingredients Market is fuelled by a higher investment by pharmaceutical and chemical companies into their research and development, along with support from various regulatory channels to undertake novel formulations of drugs.

What are future trends in the Specialty Active Pharmaceutical Ingredients (API) market?

Greener, more circular manufacturing, green chemistry, as well as stricter environmental requirements for the Specialty Active Pharmaceutical Ingredients Market, will increase over the coming years. Research and development investments in search of new, high-quality, targeted therapies will thrive. New formulations and innovation will continue to flourish, opening up new opportunities in medical science.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

  1.  Almac
  2.  AmbioPharm, Inc.
  3.  Santaris Pharma
  4.  Symbiotec Pharma Lab Pvt. Ltd
  5.  Olon SpA
  6.  Rhodes Technologies
  7.  Pfanstiehl, Inc
  8.  Dextra Laboratories Limited
  9.  FarmaBios Spa
  10.  Cepia Sanofi

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.